International Flavors & Fragrances Inc (IFF)
Valor JustoFundamental
51
Precio
$83.48
Capitalización Bursátil
$21.88B
Parte 1 · Cuánto vale la empresa
Resumen
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 de septiembre de 2026 with claude-haiku-4-5 — shared with all users
The world's largest flavour and fragrance house, competing with IFF for the same consumer-goods customers across taste, scent and active beauty ingredients.
Born from the Firmenich–DSM merger, it sells perfumery, taste and nutrition ingredients to the same food, beverage and personal-care brands IFF serves.
German flavour-and-fragrance group bidding for the same fragrance, flavour and cosmetic-ingredient contracts with global FMCG customers.
Competes head-on in taste and nutrition systems for food and beverage manufacturers, the segment where IFF places its Nourish business.
Rivals IFF's Health & Biosciences arm in enzymes, cultures and probiotics sold to the same food, beverage and household-care producers.
US specialty ingredients maker competing for the same flavour and colour supply contracts with food, beverage and personal-care brands.
Balance y Liquidez
Ingresos
$10.82B
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$279M
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
$256M
Patrimonio Neto Total
$14.15B
Pasivo Total
$11.35B
Ratio de Liquidez
2.06
Cobertura de Intereses
4.33
Deuda/EBITDA
10.71
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$90.73
Precio Actual
$83.48
Margen de Seguridad
+8.0%
Rango de Valor Justo
$58.98 - $122.49
Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.
Métodos de Estimación
Métricas de Valoración
Ratio P/E
75.89
ROE
-2.5%
Ratio P/B
1.52
P/FCF
39.44
Margen Bruto
36.5%
ROIC
3.1%
Radar de Rentabilidad
Creación de Valor (Ventaja Competitiva)
ROIC
3.1%
WACC
8.0%
ROIC − WACC
-4.9 pp
El ROIC está por debajo del coste del capital: la empresa destruye valor por cada dólar invertido.
Criterios de Análisis Fundamental
Superado (12)
- Gross Margin 36.5%
- P/B Ratio 1.52
- Debt/Equity ratio
- Operating Margin 7.5%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Revenue Growth 5Y 16.5%
- Analyst Consensus 72% Buy
- Earnings Quality (OCF/NI) 4.16
- Share Dilution -0.8%
- Piotroski F-Score 6/9
Fallido (12)
- EPS shows upward trend
- Price CAGR -3.37%
- ROIC 3.1%
- P/FCF 39.44
- CapEx intensity
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- ROE 2.1%
- Earnings Surprise avg -3.4%
No disponible (3)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
- Net Margin Trend (invalid data)
Piotroski F-Score
Señales mixtas: algunas áreas requieren atención
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Participaciones institucionales
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Jon Erik Fyrwald | CEO & Director | 66 |
| Mr. Michael DeVeau | Executive VP & CFO | 44 |
| Mr. Yuvraj Arora | President of Taste Division & Chief Commercial Officer | 53 |
| Mr. Andres Muller | President of Food Ingredients | 60 |
| Ms. Leticia Goncalves Lourenco | President of Health & Biosciences | 50 |
| Mr. Ralf Finzel Ph.D. | Executive VP & Global Operations Officer | 61 |
| Mr. Marc H. Birenkrant | Controller & Chief Accounting Officer | 52 |
| Mr. Vivek Verma | Executive VP & Chief Information Officer | 56 |
| Mr. Stephen N. Landsman Esq., J.D. | Executive VP & General Counsel | 66 |
| Ms. Deborah Borg | EVP & Chief People and Culture Officer | 48 |
Riesgo de Auditoría
5
Riesgo del Consejo
1
Riesgo de Compensación
9
Riesgo de Derechos del Accionista
6
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Documentos
- Ver documento
Informe anual (10-K)
Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.
Presentado el 2026-02-27
- Ver documento
Informe trimestral (10-Q)
Una actualización del desempeño financiero de los últimos tres meses.
Presentado el 2026-08-04
- Ver documento
Informe de hecho relevante (8-K)
Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.
Presentado el 2026-08-04
via SEC EDGAR
Historial de Resultados
via SEC EDGAR
Latest News
Recent headlines for IFF, sourced from Markets Gazette.